Heterozygous familial hypercholesterolemia in children: Low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations

Atherosclerosis

Volumn 126, Issue 1, 1996, Pages 163-171

  Torres, Ana L ^a   Moorjani, Sital ^a   Vohl, Marie Claude ^a   Gagné, Claude ^a   Lamarche, Benoît ^a   Brun, Louis Daniel ^a   Lupien, Paul J ^a   Després, Jean Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Children; Familial hypercholesterolemia; Genetic epidemiology; LDL receptor gene

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; FAMILIAL HYPERCHOLESTEROLEMIA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATION; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030604003     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05907-2     Document Type: Article

References (33)

1. [1] Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
2. [2] Kwiterovich PO Jr. Biochemical, clinical, epidemiologic, genetic, and pathologic data in the pediatric age group relevant to the cholesterol hypothesis. Pediatrics 1986;78:349-362.
3. [3] Stary Hebert C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;9(suppl I):19-I-32.
4. [4] Strong JP, McGill HC Jr. The pediatric aspects of atherosclerosis. J Atheroscler Res 1969;9:251-265.
5. [5] Kwiterovich PO Jr, Fredrickson SD, Levy RI. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic, and clinical presentation in childhood. J Clin Invest 1974;53:1237-1249.
6. [6] Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.), The Metabolic and Molecular Bases of Inherited Diseases, 7th edn. New York: McGraw-Hill, 1995;1981-2030.
7. [7] Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 1990;24;133-170.
8. [8] Leitersdorf E, van der Westhuyzen DR, Coetzee GA, Hobbs HH. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest 1989;84:954-961.
9. [9] Lehrman MA, Schneider WJ, Brown MS, et al. The lebanese allele at the low density lipoprotein receptor locus: non-sense mutation produces truncated receptor that is retained in endoplasmic reticulum. J Biol Chem 1987;262:401-410.
10. [10] Seftel HC, Baker SG, Jenkins T, Mendelson D. Prevalence of familial hypercholesterolemia in Johannesburg jews. Am J Med Genet 1989;34:545-547.
11. [11] Aalto-Setälä K, Helve KE, Konaven T, Kontula K. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype. J Clin Invest 1989;84:499-505.
12. [12] Slimane MN, Pousse H, Maatoug F, Hammami M, Ben Farhat MH. Phenotypic expression of familial hypercholesterolaemia in Central and Southern Tunisia. Atherosclerosis 1993;104:153-158.
13. [13] Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL. Deletion in the gene for the low density lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. New Engl J Med 1987;317:734-737.
14. [14] Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 1990;85:1014-1023.
15. [15] Ma Y, Bétard C, Roy M, Davignon J, Kessling AM. Identification of a second «French Canadian» LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet 1989;36:219-228.
16. [16] Simard J, Moorjani S, Vohl M-C, et al. Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians. Hum Mol Genet 1994;3:1689-1691.
17. [17] Gagné C, Moorjani S, Brun D, Toussaint M, Lupien P-J. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoprotein, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis 1979;34:13-24.
18. [18] Burstein M, Samaille J. Sur un dosage rapide du cholestérol lié aux alpha et aux bêta-lipoprotéines du sérum. Clin Chim Acta 1960;5:609-610.
19. [19] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. [20] Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
21. [21] Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
22. [22] Vohl M-C, Couture P, Moorjani S, et al. Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians. Hum Mut 1995;6:243-246.
23. [23] Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67:730-734.
24. [24] Russell DW, Brown MS, Goldstein JL. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem 1989;264:21682-21688.
25. [25] Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mut 1992;1:445-466.
26. [26] Srinivasan SR, Frerichs RR, Webber LS, Berenson GS. Serum lipoprotein profile in children from a biracial community. The Bogalusa Heart Study. Circulation 1976;54:309-318.
27. [27] Rifkind BM, Segal P. Lipid Research Clinics program reference values for hyperlipidemia and hypolipidemia. J Am Med Assoc 1983;250:1869-1872.
28. [28] Assmann G, Schulte H. Relation to high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease. (The PROCAM Experience). Am J Cardiol 1992;70:733-737.
29. [29] Castelli William P. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992;70:3H-9H.
30. [30] Reaven GM, Ida Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141-146.
31. [31] Lamarche B, Després JP, Pouliot MC, et al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 1993;13:33-40.
32. [32] Moorjani S, Gagné C, Lupien P-J, Brun D. Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism 1986;35:311-316.
33. [33] Freedman DS, Srinivasan SR, Voors AW, Webber LS, Berenson GS. High density lipoprotein and coronary artery disease risk factors in children with different lipoprotein profiles: Bogalusa Heart Study. J Chronic Dis 1985;38:327-338.